Literature DB >> 19628721

Dynamic CO2 therapy in periodic breathing: a modeling study to determine optimal timing and dosage regimes.

Yoseph Mebrate1, Keith Willson, Charlotte H Manisty, Resham Baruah, Jamil Mayet, Alun D Hughes, Kim H Parker, Darrel P Francis.   

Abstract

We examine the potential to treat unstable ventilatory control (seen in periodic breathing, Cheyne-Stokes respiration, and central sleep apnea) with carefully controlled dynamic administration of supplementary CO(2), aiming to reduce ventilatory oscillations with minimum increment in mean CO(2). We used a standard mathematical model to explore the consequences of phasic CO(2) administration, with different timing and dosing algorithms. We found an optimal time window within the ventilation cycle (covering approximately 1/6 of the cycle) during which CO(2) delivery reduces ventilatory fluctuations by >95%. Outside that time, therapy is dramatically less effective: indeed, for more than two-thirds of the cycle, therapy increases ventilatory fluctuations >30%. Efficiency of stabilizing ventilation improved when the algorithm gave a graded increase in CO(2) dose (by controlling its duration or concentration) for more severe periodic breathing. Combining gradations of duration and concentration further increased efficiency of therapy by 22%. The (undesirable) increment in mean end-tidal CO(2) caused was 300 times smaller with dynamic therapy than with static therapy, to achieve the same degree of ventilatory stabilization (0.0005 vs. 0.1710 kPa). The increase in average ventilation was also much smaller with dynamic than static therapy (0.005 vs. 2.015 l/min). We conclude that, if administered dynamically, dramatically smaller quantities of CO(2) could be used to reduce periodic breathing, with minimal adverse effects. Algorithms adjusting both duration and concentration in real time would achieve this most efficiently. If developed clinically as a therapy for periodic breathing, this would minimize excess acidosis, hyperventilation, and sympathetic overactivation, compared with static treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628721      PMCID: PMC2755997          DOI: 10.1152/japplphysiol.90308.2008

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  38 in total

1.  The causes of periodic or Cheyne-Stokes breathing.

Authors:  C G Douglas; J S Haldane
Journal:  J Physiol       Date:  1909-06-15       Impact factor: 5.182

2.  Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications.

Authors:  D P Francis; K Willson; L C Davies; A J Coats; M Piepoli
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

3.  Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure.

Authors:  P A Lanfranchi; A Braghiroli; E Bosimini; G Mazzuero; R Colombo; C F Donner; P Giannuzzi
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

4.  Apnea-hypopnea threshold for CO2 in patients with congestive heart failure.

Authors:  Ailiang Xie; James B Skatrud; Dominic S Puleo; Peter S Rahko; Jerome A Dempsey
Journal:  Am J Respir Crit Care Med       Date:  2002-05-01       Impact factor: 21.405

5.  Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence.

Authors:  Ugo Corrà; Massimo Pistono; Alessandro Mezzani; Alberto Braghiroli; Andrea Giordano; Paola Lanfranchi; Enzo Bosimini; Marco Gnemmi; Pantaleo Giannuzzi
Journal:  Circulation       Date:  2005-12-27       Impact factor: 29.690

6.  Low-concentration carbon dioxide is an effective adjunct to positive airway pressure in the treatment of refractory mixed central and obstructive sleep-disordered breathing.

Authors:  Robert Joseph Thomas; Robert W Daly; J Woodrow Weiss
Journal:  Sleep       Date:  2005-01       Impact factor: 5.849

7.  Effect of inhaled 3% CO2 on Cheyne-Stokes respiration in congestive heart failure.

Authors:  R D Steens; T W Millar; X Su; D Biberdorf; P Buckle; M Ahmed; M H Kryger
Journal:  Sleep       Date:  1994-02       Impact factor: 5.849

8.  Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure.

Authors:  P J Hanly; N S Zuberi-Khokhar
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

9.  A simple breathing circuit minimizing changes in alveolar ventilation during hyperpnoea.

Authors:  L Z Sommer; S Iscoe; A Robicsek; J Kruger; J Silverman; J Rucker; J Dickstein; G A Volgyesi; J A Fisher
Journal:  Eur Respir J       Date:  1998-09       Impact factor: 16.671

10.  Experimentally induced Cheyne-Stokes breathing.

Authors:  N S Cherniack; C von Euler; I Homma; F F Kao
Journal:  Respir Physiol       Date:  1979-07
View more
  8 in total

Review 1.  Impact of concomitant medications on obstructive sleep apnoea.

Authors:  Ingrid Jullian-Desayes; Bruno Revol; Elisa Chareyre; Philippe Camus; Céline Villier; Jean-Christian Borel; Jean-Louis Pepin; Marie Joyeux-Faure
Journal:  Br J Clin Pharmacol       Date:  2016-11-24       Impact factor: 4.335

Review 2.  Dynamic CO₂ inhalation: a novel treatment for CSR-CSA associated with CHF.

Authors:  Zhi Hui Wan; Fang Jing Wen; Ke Hu
Journal:  Sleep Breath       Date:  2012-05-24       Impact factor: 2.816

Review 3.  Congestive heart failure and central sleep apnea.

Authors:  Scott A Sands; Robert L Owens
Journal:  Crit Care Clin       Date:  2015-07       Impact factor: 3.598

4.  Effects of stabilizing or increasing respiratory motor outputs on obstructive sleep apnea.

Authors:  Ailiang Xie; Mihaela Teodorescu; David F Pegelow; Mihai C Teodorescu; Yuansheng Gong; Jessica E Fedie; Jerome A Dempsey
Journal:  J Appl Physiol (1985)       Date:  2013-04-18

5.  Contemporary insights and novel treatment approaches to central sleep apnea syndrome in heart failure.

Authors:  Ryan L Grayburn; Yaquta Kaka; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-07

6.  Influence of cerebral blood flow on central sleep apnea at high altitude.

Authors:  Keith R Burgess; Samuel J E Lucas; Kelly Shepherd; Andrew Dawson; Marianne Swart; Kate N Thomas; Rebekah A I Lucas; Joseph Donnelly; Karen C Peebles; Rishi Basnyat; Philip N Ainslie
Journal:  Sleep       Date:  2014-10-01       Impact factor: 5.849

7.  Novel cardiac pacemaker-based human model of periodic breathing to develop real-time, pre-emptive technology for carbon dioxide stabilisation.

Authors:  Resham Baruah; Alberto Giannoni; Keith Willson; Charlotte H Manisty; Yoseph Mebrate; Andreas Kyriacou; Hemang Yadav; Beth Unsworth; Richard Sutton; Jamil Mayet; Alun D Hughes; Darrel P Francis
Journal:  Open Heart       Date:  2014-08-12

8.  Pre-Treatment with Ten-Minute Carbon Dioxide Inhalation Prevents Lipopolysaccharide-Induced Lung Injury in Mice via Down-Regulation of Toll-Like Receptor 4 Expression.

Authors:  Shih-En Tang; Shu-Yu Wu; Shi-Jye Chu; Yuan-Sheng Tzeng; Chung-Kan Peng; Chou-Chin Lan; Wann-Cherng Perng; Chin-Pyng Wu; Kun-Lun Huang
Journal:  Int J Mol Sci       Date:  2019-12-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.